Phase ii clinical trial, testing the efficacy of a humanized monoclonal antibody against the Lewis-Y antigen (Le y)

Mastology ◽

10.29289/259453942018v28s1013 ◽

2018 ◽

Vol 28 (s1) ◽

pp. 11-11

Author(s):

Laura Testa ◽

◽

Ruffo Freitas- Junior ◽

Sergio V Serrano ◽

Roberto J Arai ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Lewis Y Antigen ◽

Humanized Monoclonal Antibody ◽

Trial Testing ◽

Download Full-text

Abstract P1-12-02: Clinical efficacy of a humanized monoclonal antibody against the Lewis-Y antigen (Ley): Results of a phase II clinical trial

10.1158/1538-7445.sabcs17-p1-12-02 ◽

2018 ◽

Author(s):

L Testa ◽

SV Serrano ◽

RJ Arai ◽

MC Zorzetto ◽

R Freitas-Junior ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Phase Ii ◽

Clinical Efficacy ◽

Phase Ii Clinical Trial ◽

Lewis Y Antigen ◽

Humanized Monoclonal Antibody ◽

Download Full-text

Recombinant Humanized Monoclonal Antibody against CD18 (rhu MAb CD18) in Traumatic Hemorrhagic Shock: Results of a Phase II Clinical Trial

Journal of Trauma and Acute Care Surgery ◽

10.1097/00005373-200010000-00007 ◽

2000 ◽

Vol 49 (4) ◽

pp. 611-620 ◽

Author(s):

Peter Rhee ◽

John Morris ◽

Rodney Durham ◽

Carl Hauser ◽

Mark Cipolle ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Hemorrhagic Shock ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Humanized Monoclonal Antibody ◽

Traumatic Hemorrhagic Shock

Download Full-text

A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-0284 ◽

2007 ◽

Vol 13 (11) ◽

pp. 3286-3292 ◽

Author(s):

Andrew M. Scott ◽

Niall Tebbutt ◽

Fook-Thean Lee ◽

Tina Cavicchiolo ◽

Zhanqi Liu ◽

...

Keyword(s):

Monoclonal Antibody ◽

Phase I ◽

Epithelial Cancers ◽

Lewis Y Antigen ◽

Humanized Monoclonal Antibody ◽

Download Full-text

Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181560dcc ◽

2007 ◽

Vol 2 (10) ◽

pp. 947-952 ◽

Author(s):

Lee M. Krug ◽

Daniel T. Milton ◽

Achim A. Jungbluth ◽

Lin-Chi Chen ◽

Emilio Quaia ◽

...

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Small Cell Lung Cancer ◽

Pilot Trial ◽

Small Cell Lung ◽

Humanized Monoclonal Antibody ◽

Trial Testing ◽

Lewis Y ◽

Download Full-text

Population Pharmacokinetics of Rituximab (Anti-CD20 Monoclonal Antibody) in Rheumatoid Arthritis Patients During a Phase II Clinical Trial

The Journal of Clinical Pharmacology ◽

10.1177/0091270005277075 ◽

2005 ◽

Vol 45 (7) ◽

pp. 792-801 ◽

Author(s):

Chee M. Ng ◽

Rene Bruno ◽

Dan Combs ◽

Brian Davies

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Monoclonal Antibody ◽

Population Pharmacokinetics ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Download Full-text

A Multi-Center Phase II Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody Amatuximab in Combination with Chemotherapy for Frontline Therapy of Malignant Pleural Mesothelioma: Updated Clinical Outcomes and Correlative Studies

Annals of Oncology ◽

10.1016/s0923-7534(20)34090-4 ◽

2012 ◽

Vol 23 ◽

pp. ix493

Author(s):

M. Reck ◽

R. Hassan ◽

T. Jahan ◽

H.L. Kindler ◽

L. Bazhenova ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Clinical Outcomes ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Frontline Therapy ◽

Correlative Studies

Download Full-text

EFFECTS OF ALIROCUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ON LIPOPROTEIN PARTICLE CONCENTRATIONS DETERMINED BY NUCLEAR MAGNETIC RESONANCE: SUBSTUDY OF A RANDOMIZED DOUBLE-BLIND PHASE II CLINICAL TRIAL

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)61373-5 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1373 ◽

Author(s):

Michael J. Koren ◽

Dean Kereiakes ◽

Ray Pourfarzib ◽

Deborah Winegar ◽

Poulabi Banerjee ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Nuclear Magnetic Resonance ◽

Magnetic Resonance ◽

Phase Ii ◽

Human Monoclonal Antibody ◽

Phase Ii Clinical Trial ◽

Proprotein Convertase ◽

Double Blind ◽

Lipoprotein Particle

Download Full-text

Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab

International Journal of Oncology ◽

10.3892/ijo.2012.1539 ◽

2012 ◽

Vol 41 (3) ◽

pp. 1029-1035 ◽

Author(s):

SHASHA LV ◽

ERIK TEUGELS ◽

JAN SADONES ◽

SYLVIA DE BRAKELEER ◽

JOHNNY DUERINCK ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Phase Ii ◽

Recurrent Glioblastoma ◽

Phase Ii Clinical Trial

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

A result of phase II clinical trial for the dermatomycosis of new antifungus external preparation KP-363 ( butenafine hydrochloride ) cream and liquid.

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.52.586 ◽

1990 ◽

Vol 52 (3) ◽

pp. 586-595 ◽

Author(s):

AKIRA OKAWARA

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text